Market Overview:
The global generic injectables market reached a value of US$ 40.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 65.4 Billion by 2027, exhibiting at a CAGR of 8.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A generic injectable is a drug formulated with the same active pharmaceutical ingredient as its branded counterpart in strength, dosage form, safety, performance, quality, intended use, side effects, and route of administration. It is as safe and effective as the innovator drug and is consequently used for administering the medication rapidly into the body. It facilitates the easy absorption of medicines in liquid form, which helps reduce the frequency of dosage administration without affecting the efficacy of the treatment. Besides this, it is cost-effective and does not require investment in testing, promotional activities, and research and development (R&D) compared to its branded counterparts. As a result, generic injectables are extensively utilized in treating cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, and respiratory, neurological, and cardiovascular disorders.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Generic Injectables Market Trends:
The growing global geriatric population, which is more susceptible to several chronic medical ailments, such as diabetes, cancer, and cardiovascular diseases, represents one of the key factors driving the demand for generic injectables worldwide. In addition, the rising occurrence of lifestyle disorders due to hectic schedules, changing dietary patterns, and sedentary lifestyles of individuals are positively influencing the market. Apart from this, initiatives undertaken by governing authorities of numerous countries to support key manufacturers and sellers are offering lucrative growth opportunities to manufacturers. This, along with the widespread adoption of advanced technologies in the manufacturing process of generic injectables, is propelling the market growth. Furthermore, the expansion of offline pharmacies, along with the easy availability of generic injectables via online pharmacies, is offering a favorable market outlook. The emerging trend of online shopping offers consumers a wide range of products, free doorstep delivery, exciting deals and discounts, and secured payment methods is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global generic injectables market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on therapeutic area, container, and distribution channel.
Breakup by Therapeutic Area:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The oncology segment currently dominates the market due to the increasing number of cancer patients.
Breakup by Container:
On the basis of the container, the market has been segmented into vials, ampoules, premix, and prefilled syringes.
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
Hospitals hold the largest market share due to the increasing cases of chronic medical disorders and the growing expansion of hospitals across the globe.
Regional Insights:
To get more information on the regional analysis of this market, Request Sample
- Europe
- North America
- Asia
- Latin America
- Middle East and Africa
North America enjoys the leading position in the market due to the existence of various leading manufacturers in the country.
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being
- Hospira (Pfizer)
- Fresenius Kabi
- Hikma
- Sandoz (Novartis)
- Sagent
- Sanofi
- Baxter
This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Therapeutic Area, Container, Distribution Channel, Region |
| Region Covered |
Asia, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered |
Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
5.5 Major Players
6 Global Generic Drug Delivery Market
6.1 Oral
6.2 Injectables
6.3 Dermal/Topical
6.4 Inhalers
7 Global Generic Injectables Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Region
7.5 Market Breakup by Therapeutic Area
7.6 Market Breakup by Container
7.7 Market Breakup by Distribution Channel
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porter’s Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
7.12 Key Market Drivers and Success Factors
8 Global Generic Injectables Market: Performance of Key Regions
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Latin America
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market by Therapeutic Area
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anaesthesia
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Anti-infectives
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Parenteral Nutrition
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Cardiovascular
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market by Container
10.1 Vials
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ampoules
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Premix
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Prefilled Syringes
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market by Distribution Channel
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacy
11.2.1 Market Trends
11.2.2 Market Forecast
12 Global Generic Injectables Market: Competitive Landscape
12.1 Market Structure
12.2 Market Breakup by Key Players
13 Generic Injectables Manufacturing Process
13.1 Product Overview
13.2 Detailed Process Flow (Injectables)
13.3 Various Types of Unit Operations Involved
13.4 Mass Balance and Raw Material Requirements
14 Project Details, Requirements and Costs Involved
14.1 Land Requirements and Expenditures
14.2 Construction Requirements and Expenditures
14.3 Plant Machinery
14.4 Machinery Pictures
14.5 Raw Material Requirements and Expenditures
14.6 Packaging Requirements and Expenditures
14.7 Transportation Requirements and Expenditures
14.8 Utility Requirements and Expenditures
14.9 Manpower Requirements and Expenditures
14.10 Other Capital Investments
15 Loans and Financial Assistance
16 Project Economics
16.1 Capital Cost of the Project
16.2 Techno-Economic Parameters
16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
16.4 Taxation and Depreciation
16.5 Income Projections
16.6 Expenditure Projections
16.7 Financial Analysis
16.8 Profit Analysis
17 Key Player Profiles
17.1 Hospira (Pfizer)
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Financials
17.1.4 SWOT Analysis
17.2 Fresenius Kabi
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Financials
17.2.4 SWOT Analysis
17.3 Hikma
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Financials
17.3.4 SWOT Analysis
17.4 Sandoz (Novartis)
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Financials
17.4.4 SWOT Analysis
17.5 Sagent
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Financials
17.5.4 SWOT Analysis
17.6 Sanofi
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Financials
17.6.4 SWOT Analysis
17.7 Baxter
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Financials
17.7.4 SWOT Analysis
List of Figures
Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2016 - 2021
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2021
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2016, 2021 & 2027
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2016, 2021 & 2027
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2016, 2021 & 2027
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2016, 2021 & 2027
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2016 - 2021
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2021
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2021
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2022-2027
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 19: Europe: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 21: Asia: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2016 & 2021
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2022-2027
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2016 & 2021
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2016 & 2021
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2016 & 2021
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2016 & 2021
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2016 & 2021
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2016 & 2021
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2016 & 2021
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2016 & 2021
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2016 & 2021
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2022-2027
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2016 & 2021
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2022-2027
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2016 & 2021
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2022-2027
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2022-2027
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2022-2027
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)